Form 13-F position report

DEFINITIVE HEALTHCARE CORP

Reported by Connor Clark & Lunn Investment Management Ltd

DH CUSIP 24477E103 Manager CIK 0001596800

Reported 361,046 shares, up 110,894 (44.3%) from the prior quarter.

Reported value 94.8%; share count 44.3% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2025
Shares 361,046 Quarter-end amount reported
Reported value $1,408,079 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 664591
2023-06-30 1011846
2023-09-30 0
2024-09-30 512047
2024-12-31 602621
2025-03-31 722939
2025-06-30 1408079
2025-09-30 1036274
2025-12-31 634227
2026-03-31 45685
2026-06-30 11748

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for DEFINITIVE HEALTHCARE CORP held by Connor Clark & Lunn Investment Management Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 14,139 -23,003 (-61.9%) < 0.01% $11,748 2026-08-13
Q1 2026 Reduced 37,142 -183,843 (-83.2%) < 0.01% $45,685 2026-05-11
Q4 2025 Reduced 220,985 -34,255 (-13.4%) < 0.01% $634,227 2026-02-10
Q3 2025 Reduced 255,240 -105,806 (-29.3%) < 0.01% $1,036,274 2025-11-13
Q2 2025 Added 361,046 +110,894 (44.3%) < 0.01% $1,408,079 2025-08-07
Q1 2025 Added 250,152 +103,529 (70.6%) < 0.01% $722,939 2025-05-12
Q4 2024 Added 146,623 +32,071 (28.0%) < 0.01% $602,621 2025-02-10
Q3 2024 New 114,552 +114,552 (0.0%) < 0.01% $512,047 2024-11-08
Q3 2023 Reduced 0 -91,986 (-100.0%) 0 $0 2023-11-13
Q2 2023 Added 91,986 +27,650 (43.0%) < 0.01% $1,011,846 2023-08-10
Q1 2023 New 64,336 +64,336 (0.0%) < 0.01% $664,591 2023-05-10

Who else reported the position

157 managers reported DEFINITIVE HEALTHCARE CORP for Q2 2025.

Managers reporting DEFINITIVE HEALTHCARE CORP in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ADVENT INTERNATIONAL CORP MA Unchanged 62,493,676 0 7.91% $243,725,336 16 qtrs
The Goldman Sachs Group Inc Added 8,742,267 +25,542 < 0.01% $34,094,841 16 qtrs
BlackRock Inc Reduced 3,115,568 -969,126 < 0.01% $12,150,715 4 qtrs
VANGUARD GROUP INC Reduced 2,924,608 -903,689 < 0.01% $11,405,971 16 qtrs
PALISADE CAPITAL MANAGEMENT LLC NJ Reduced 2,183,143 -82,055 0.24% $8,514,258 9 qtrs
DIMENSIONAL FUND ADVISORS LP Added 2,039,585 +72,411 < 0.01% $7,953,868 11 qtrs
MORGAN STANLEY Added 1,552,185 +229,668 < 0.01% $6,053,523 16 qtrs
D E Shaw & Co Inc Added 1,409,099 +538,008 < 0.01% $5,495,486 11 qtrs
STATE STREET CORPORATION Reduced 1,188,645 -190,424 < 0.01% $4,635,716 15 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 1,129,895 -111,721 < 0.01% $4,408,109 16 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 07, 2025
Filing type
13F-HR
Position type
CLASS A COM

Voting authority reported

Sole
361,046
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.